 |
 Video: What is a Stock Split?
|
|
|
| OmniAb is a biotechnology company with a Biological Intelligence™ antibody platform for the discovery of mono and bispecific therapeutic human antibodies. The OmniAb technology platform provides the Biological Intelligence of Co.'s transgenic animals, including OmniRat®, OmniMouse® and OmniChicken®, that have been modified to generate antibodies with human sequences to facilitate development of human therapeutic candidates. OmniFlic® and OmniClic® are light-chain rats and chickens, respectively, designed to generate bispecific antibodies. OmniTaur™ provides cow-inspired antibodies with structural characteristics for related targets. According to our OmniAb stock split history records, OmniAb has had 0 splits. | |
|
OmniAb (OABI) has 0 splits in our OmniAb stock split history database.
Looking at the OmniAb stock split history from start to finish, an original position size of 1000 shares would have turned into 1000 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into OmniAb shares, starting with a $10,000 purchase of OABI, presented on a split-history-adjusted basis factoring in the complete OmniAb stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
09/30/2021 |
|
| End date: |
05/03/2024 |
|
| Start price/share: |
$9.76 |
|
| End price/share: |
$4.67 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-52.15% |
|
| Average Annual Total Return: |
-24.75% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$4,785.55 |
|
| Years: |
2.59 |
|
|
|
|
|
